Macrolides (alone or in combination) should be used as first-line empirical therapy of community-acquired pneumonia in children: myth or maxim?

Macrolides should not be used as first-line therapy for community-acquired pneumonia in children as no clinical benefit is shown and widespread use is associated with an emerging increase in macrolide resistance amongst S. pneumoniae and M. pneumoniae https://bit.ly/3yQuedF

Detalles Bibliográficos
Autor principal: Warris, Adilia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753631/
https://www.ncbi.nlm.nih.gov/pubmed/35035545
http://dx.doi.org/10.1183/20734735.0056-2021
_version_ 1784632131459219456
author Warris, Adilia
author_facet Warris, Adilia
author_sort Warris, Adilia
collection PubMed
description Macrolides should not be used as first-line therapy for community-acquired pneumonia in children as no clinical benefit is shown and widespread use is associated with an emerging increase in macrolide resistance amongst S. pneumoniae and M. pneumoniae https://bit.ly/3yQuedF
format Online
Article
Text
id pubmed-8753631
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-87536312022-01-13 Macrolides (alone or in combination) should be used as first-line empirical therapy of community-acquired pneumonia in children: myth or maxim? Warris, Adilia Breathe (Sheff) Viewpoint Macrolides should not be used as first-line therapy for community-acquired pneumonia in children as no clinical benefit is shown and widespread use is associated with an emerging increase in macrolide resistance amongst S. pneumoniae and M. pneumoniae https://bit.ly/3yQuedF European Respiratory Society 2021-09 /pmc/articles/PMC8753631/ /pubmed/35035545 http://dx.doi.org/10.1183/20734735.0056-2021 Text en Copyright ©ERS 2021 https://creativecommons.org/licenses/by-nc/4.0/Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
spellingShingle Viewpoint
Warris, Adilia
Macrolides (alone or in combination) should be used as first-line empirical therapy of community-acquired pneumonia in children: myth or maxim?
title Macrolides (alone or in combination) should be used as first-line empirical therapy of community-acquired pneumonia in children: myth or maxim?
title_full Macrolides (alone or in combination) should be used as first-line empirical therapy of community-acquired pneumonia in children: myth or maxim?
title_fullStr Macrolides (alone or in combination) should be used as first-line empirical therapy of community-acquired pneumonia in children: myth or maxim?
title_full_unstemmed Macrolides (alone or in combination) should be used as first-line empirical therapy of community-acquired pneumonia in children: myth or maxim?
title_short Macrolides (alone or in combination) should be used as first-line empirical therapy of community-acquired pneumonia in children: myth or maxim?
title_sort macrolides (alone or in combination) should be used as first-line empirical therapy of community-acquired pneumonia in children: myth or maxim?
topic Viewpoint
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753631/
https://www.ncbi.nlm.nih.gov/pubmed/35035545
http://dx.doi.org/10.1183/20734735.0056-2021
work_keys_str_mv AT warrisadilia macrolidesaloneorincombinationshouldbeusedasfirstlineempiricaltherapyofcommunityacquiredpneumoniainchildrenmythormaxim

Ejemplares similares